238 related articles for article (PubMed ID: 19282029)
1. Estimating the prevalence of myelodysplastic syndromes in patients with unexplained cytopenias: a retrospective study of 322 bone marrows.
Buckstein R; Jang K; Friedlich J; Zhang L; Reis M; Chesney A; Wells RA
Leuk Res; 2009 Oct; 33(10):1313-8. PubMed ID: 19282029
[TBL] [Abstract][Full Text] [Related]
2. Validation of a scoring system to establish the probability of myelodysplastic syndrome in patients with unexplained cytopenias or macrocytosis.
Rauw J; Wells RA; Chesney A; Reis M; Zhang L; Buckstein R
Leuk Res; 2011 Oct; 35(10):1335-8. PubMed ID: 21704372
[TBL] [Abstract][Full Text] [Related]
3. [Hematological characteristics in primary myelodysplastic syndromes: retrospective study of 14 cases].
Elloumi M; Frikha M; Haddouk Y; Makni F; Souissi T
Tunis Med; 1993; 71(6-7):333-8. PubMed ID: 8249207
[No Abstract] [Full Text] [Related]
4. [A feature of hematological findings in myelodysplastic syndromes].
Bando S; Niiya T; Murase M; Makino H
Rinsho Byori; 1998 Aug; 46(8):790-5. PubMed ID: 9760831
[TBL] [Abstract][Full Text] [Related]
5. Myelodysplastic syndromes: more prevalent than we know.
Sandhu SK; Sekeres MA
Geriatrics; 2008 Nov; 63(11):10-7. PubMed ID: 18998762
[TBL] [Abstract][Full Text] [Related]
6. International MDS risk analysis workshop (IMRAW)/IPSS reanalyzed: impact of cytopenias on clinical outcomes in myelodysplastic syndromes.
Kao JM; McMillan A; Greenberg PL
Am J Hematol; 2008 Oct; 83(10):765-70. PubMed ID: 18645988
[TBL] [Abstract][Full Text] [Related]
7. Therapy may unmask hypoplastic myelodysplastic syndrome that mimics aplastic anemia.
Konoplev S; Medeiros LJ; Lennon PA; Prajapati S; Kanungo A; Lin P
Cancer; 2007 Oct; 110(7):1520-6. PubMed ID: 17701956
[TBL] [Abstract][Full Text] [Related]
8. The spectrum of myelodysplastic syndromes post-solid organ transplantation: a single institutional experience.
Menes M; Vakiani E; Keller CE; Ho EK; Colovai A; Nichols G; Diuguid D; Mears JG; Murty VV; Alobeid B; Bhagat G
Leuk Res; 2007 Jan; 31(1):59-65. PubMed ID: 16787662
[TBL] [Abstract][Full Text] [Related]
9. Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes.
Neukirchen J; Blum S; Kuendgen A; Strupp C; Aivado M; Haas R; Aul C; Gattermann N; Germing U
Eur J Haematol; 2009 Nov; 83(5):477-82. PubMed ID: 19548919
[TBL] [Abstract][Full Text] [Related]
10. Hypocellularity in myelodysplastic syndrome is an independent factor which predicts a favorable outcome.
Yue G; Hao S; Fadare O; Baker S; Pozdnyakova O; Galili N; Woda BA; Raza A; Wang SA
Leuk Res; 2008 Apr; 32(4):553-8. PubMed ID: 17888511
[TBL] [Abstract][Full Text] [Related]
11. Increased angiogenesis in the bone marrow of HIV-positive patients with myelodysplasia.
Patsouris E; Korkolopoulou P; Androulaki A; Douzinas E; Kosmopoulou O; Kordossis T
Pathology; 2003 Aug; 35(4):330-5. PubMed ID: 12959769
[TBL] [Abstract][Full Text] [Related]
12. The incidence and impact of thrombocytopenia in myelodysplastic syndromes.
Kantarjian H; Giles F; List A; Lyons R; Sekeres MA; Pierce S; Deuson R; Leveque J
Cancer; 2007 May; 109(9):1705-14. PubMed ID: 17366593
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of dysmyelopoiesis in cats: 34 cases (1996-2005).
Weiss DJ
J Am Vet Med Assoc; 2006 Mar; 228(6):893-7. PubMed ID: 16536701
[TBL] [Abstract][Full Text] [Related]
14. Pediatric patients with bicytopenia/pancytopenia: review of etiologies and clinico-hematological profile at a tertiary center.
Naseem S; Varma N; Das R; Ahluwalia J; Sachdeva MU; Marwaha RK
Indian J Pathol Microbiol; 2011; 54(1):75-80. PubMed ID: 21393882
[TBL] [Abstract][Full Text] [Related]
15. [The myelodysplastic syndrome and autoimmunity].
Laursen SB; Nielsen MØ; Hasselbalch HC
Ugeskr Laeger; 2009 Sep; 171(37):2639-42. PubMed ID: 19758507
[TBL] [Abstract][Full Text] [Related]
16. [Dyshemopoietic anemias (AD) (myelodysplastic syndromes). Retrospective analysis of 40 cases from the Instituto Nacional de la Nutrición Salvador Zubirán (INNSZ)].
Lobato-Mendizábal E; Labardini-Méndez J; Gallardo-Rincón D
Rev Invest Clin; 1989; 41(1):17-24. PubMed ID: 2727429
[TBL] [Abstract][Full Text] [Related]
17. Clinical presentation, diagnosis, and prognosis of myelodysplastic syndromes.
Foran JM; Shammo JM
Am J Med; 2012 Jul; 125(7 Suppl):S6-13. PubMed ID: 22735753
[TBL] [Abstract][Full Text] [Related]
18. [Peculiarities of cytogenetic changes in different types of myelodysplastic syndrome].
Lozyns'ka MP; Vyhovs'ka IaI; Tomashevs'ka NIa; Masliak ZV; Lozyns'kyĭ RIu; Novak VL
Tsitol Genet; 2009; 43(1):61-8. PubMed ID: 19663317
[TBL] [Abstract][Full Text] [Related]
19. Reduction in multi-lineage and erythroid progenitors distinguishes myelodysplastic syndromes from non-malignant cytopenias.
Vercauteren SM; Bashashati A; Wu D; Brinkman RR; Eaves C; Eaves A; Karsan A
Leuk Res; 2009 Dec; 33(12):1636-42. PubMed ID: 19414193
[TBL] [Abstract][Full Text] [Related]
20. A study of the haematologic spectrum of myelodysplastic syndrome.
Kini J; Khadilkar UN; Dayal JP
Indian J Pathol Microbiol; 2001 Jan; 44(1):9-12. PubMed ID: 12561987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
